RIMOXCLAMIN: New therapeutic regimen for Hansen’s Disease cure based on effective sensitivity recovery

RIMOXCLAMIN: New therapeutic regimen for Hansen’s Disease cure based on effective sensitivity recovery

Background: World Health Organization (WHO) has recommended Multidrug Therapy (MDT/WHO) for Hansen’s Disease (HD) since 1982; nevertheless, relapse, antimicrobial resistance, and adverse reactions indicate the need for new therapeutic regimens. We evaluated the efficacy and safety of the new anti-HD...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Andrey Cipriani Frade, Gustavo Sartori Albertino, Filipe Rocha Lima, Natália Aparecida de Paula, Fabiana Aparecida Correa Cinto, Fernanda Cruz Perecin, Andrezza Westin, Wilson Marques Junior, Helena Barbosa Lugão
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
Hansen’s disease
Leprosy
RIMOXCLAMIN
Treatment
Sensitivity
Multidrug therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S141386702500042X
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

http://www.sciencedirect.com/science/article/pii/S141386702500042X

Similar Items